Bacillus subtilis (Bacillaceae): The Spore-Forming Versatile Probiotic for Human, Animal, and Plant Health

Overview

Bacillus subtilis is a Gram-positive, rod-shaped bacterium renowned for its exceptional adaptability and its status as one of the most extensively studied and versatile probiotics in existence. Unlike many probiotic genera that are vegetative and fragile, Bacillus subtilis forms durable, heat-resistant endospores that function as nature's time capsules, allowing it to survive extreme conditions that would rapidly kill other beneficial bacteria. This spore-forming capability positions it as a robust and reliable probiotic for human health, a powerful plant growth promoter and biocontrol agent in sustainable agriculture, and a valuable feed additive in livestock and aquaculture operations.

Its presence is widespread across diverse environments, from soil and water to the gastrointestinal tracts of humans and animals, reflecting its remarkable ecological plasticity. Recent research from 2025 and 2026 has continued to unveil its sophisticated mechanisms, from precisely engineering its own cell shape for survival to producing a vast arsenal of antimicrobial peptides that target specific pathogens. Its safety is firmly established with Generally Recognized as Safe (GRAS) status from regulatory bodies, and its stability at ambient temperatures for years makes it a commercially attractive and effective probiotic for a multitude of applications.

---

Where It Is Found

Bacillus subtilis is a cosmopolitan bacterium, meaning it is found in a remarkable diversity of habitats across the globe.

Primary Habitats

· Soil: It is a ubiquitous and dominant member of the soil microbiome, where it plays a vital role in nutrient cycling and the suppression of plant pathogens.

· Water: It can be isolated from various freshwater and marine environments.

· Plant Surfaces (Rhizosphere and Phyllosphere): It thrives in close association with plants, colonizing root surfaces (the rhizosphere) and aerial parts (the phyllosphere), where it acts as a plant growth-promoting rhizobacterium (PGPR).

· Gastrointestinal Tract: It is considered a normal, though transient, gut commensal in humans and various animals, including cattle, poultry, and swine.

· Fermented Foods: It is present in some traditional fermented foods, most notably the Japanese fermented soybean product, nattō, which is rich in Bacillus subtilis var. natto.

Factors Affecting Abundance

Its abundance in the environment and gut is dynamic and influenced by several factors

· Soil type and health, with richer soils supporting larger populations

· Agricultural practices, such as crop rotation and pesticide use

· Host diet and health status, which affect colonization in the gut

· Climate and geographic location, with its spores enabling survival in extreme environments like the arid Caatinga biome

External Sources

Unlike obligate gut anaerobes, Bacillus subtilis is acquired primarily from environmental sources. Its durable spores are ingested from soil, water, and plant material, and they transiently colonize the gut after germination.

---

1. Taxonomic Insights

Scientific Name: Bacillus subtilis (Ehrenberg 1835) Cohn 1872

Family: Bacillaceae

Phylum: Bacillota (formerly Firmicutes)

Taxonomic Note

Bacillus subtilis, commonly known as the hay bacillus or grass bacillus, holds a cherished place in the history of microbiology. It was one of the first named bacterial species and has served as a model organism for studying Gram-positive biology, cellular differentiation, and metabolism for over a century. Recent taxonomic refinements have led to the reclassification of some strains previously identified as B. subtilis. Three former subspecies are now recognized as distinct species: Bacillus inaquosorum, Bacillus spizizenii, and Bacillus stercoris. Therefore, some commercial products may contain these newly classified, closely related species.

Genomic Insights

The genome of Bacillus subtilis is remarkably dynamic and reflects its adaptable lifestyle. The type strain 168 has a well-characterized circular chromosome of approximately 4.2 million base pairs with a GC content of around 43.5 percent. However, genome size can vary between strains. For example, the plant growth-promoting strain BSS.2162, isolated from the Brazilian Caatinga biome, has a 4.1 Mb genome encoding 4,077 coding sequences. Its genome harbors a rich repertoire of genes for

· Sporulation and germination, enabling its durable life cycle

· Synthesis of a vast array of secondary metabolites, including over two dozen different antibiotics

· Production of hydrolytic enzymes such as proteases, amylases, and cellulases

· Stress response and adaptation to environmental fluctuations, including genes for osmotolerance and antioxidant defense

· Motility and chemotaxis, allowing it to navigate towards nutrients

Family Characteristics

The Bacillaceae family is characterized by its members' ability to form endospores under conditions of nutrient deprivation or environmental stress. These spores are highly resistant to heat, desiccation, UV radiation, and chemicals, making this family exceptionally resilient.

Related Species

· Bacillus coagulans: Another spore-forming probiotic often used for similar applications, though with different metabolic properties.

· Bacillus clausii: A spore-forming probiotic commonly used for antibiotic-associated diarrhea and respiratory tract infections.

· Bacillus amyloliquefaciens: A close relative renowned for its potent antimicrobial production and plant growth-promoting abilities, often confused with B. subtilis.

· Bacillus licheniformis: Another industrially important species used for enzyme production and as a probiotic.

---

2. Therapeutic Actions

Primary Actions

· Spore-forming probiotic (survives stomach acid and processing)

· Antimicrobial producer (broad-spectrum antibacterial and antifungal)

· Immunomodulator (enhances immune cell activity)

· Digestive enzyme producer (amylase, protease, lipase, cellulase)

· Competitive exclusion agent (against pathogens)

· Oxygen consumer (creates anaerobic niche for beneficial bacteria)

Secondary Actions

· Plant growth promoter (PGPR)

· Biocontrol agent (suppresses soil-borne pathogens)

· Environmental stress mitigator (in plants and potentially animals)

· Gut barrier supporter (indirect effects via microbiome modulation)

· Nutrient solubilizer (phosphorus, potassium, iron)

---

3. Bioactive Components and Their Action

Endospores

The endospore is the defining feature of Bacillus subtilis and the foundation of its probiotic success. It is a dormant, highly durable structure formed within the vegetative cell when nutrients are scarce.

· Extreme Stability: The spore's multilayered coat and dehydrated core protect its DNA and essential components from extreme heat (surviving up to 95°C during feed pelleting), stomach acid, bile salts, and long-term storage. This allows for a shelf life of 24 to 36 months at ambient temperatures without refrigeration, a significant advantage over vegetative probiotics.

· Germination and Colonization: Upon reaching the small intestine, spores encounter specific germination triggers such as amino acids and sugars. They then germinate into metabolically active vegetative cells that can transiently colonize the gut, though they do not permanently establish like some anaerobic commensals.

· Transient Activity: During their temporary residence, these vegetative cells produce enzymes, antimicrobials, and other bioactive molecules that exert their beneficial effects before being eliminated.

Antimicrobial Peptides and Lipopeptides

Bacillus subtilis is a prolific factory for a diverse array of antimicrobial compounds, many of which are synthesized non-ribosomally. These are its primary weapons against microbial competitors.

· Surfactin: This cyclic lipopeptide is one of the most powerful biosurfactants known. It disrupts cell membranes of pathogenic bacteria, viruses, and mycoplasma. It also has antiviral properties against enveloped viruses and exhibits synergistic activity with other antibiotics.

· Iturin Family (Iturin A, Bacillomycin D, Mycosubtilin): These are potent antifungal lipopeptides that act by disrupting fungal cell membranes, causing leakage of intracellular contents. They are highly effective against a wide range of plant and human fungal pathogens.

· Fengycins (Plipastatin): These lipopeptides also exhibit strong antifungal activity, particularly against filamentous fungi, by perturbing the lipid bilayer of the cell membrane.

· Subtilosin A: A bacteriocin with a unique cyclic structure and broad-spectrum activity against Gram-positive and Gram-negative bacteria, including Listeria and Gardnerella.

· Sublancin 168: A lantibiotic (a class of bacteriocin) with activity against other Gram-positive bacteria, including Bacillus species and Streptococcus.

· Bacilysin: A non-ribosomally synthesized dipeptide antibiotic that is active against a broad range of bacteria and fungi. It is taken up by target cells and further processed to release an active anticapsin component.

· Difficidin and Bacillaene: These are polyketide compounds with potent antibacterial activity, particularly against Gram-negative bacteria like Escherichia coli and Erwinia amylovora.

Hydrolytic Enzymes

Vegetative cells of Bacillus subtilis secrete a powerful cocktail of digestive enzymes that enhance nutrient breakdown and availability.

· Proteases: Break down proteins into smaller peptides and amino acids, aiding digestion and reducing allergenic potential of some feed components.

· Amylases: Hydrolyze starch into simpler sugars, improving energy extraction from feed.

· Lipases: Break down fats into fatty acids and glycerol.

· Cellulases: Degrade cellulose, a major component of plant fiber that is otherwise indigestible for monogastric animals, unlocking additional energy from feed.

· Phytases: Break down phytate, a form of phosphorus in plants, releasing digestible phosphorus and reducing phosphorus pollution in manure.

Exopolysaccharides (EPS)

Bacillus subtilis produces exopolysaccharides as a key component of its biofilm matrix. In agricultural settings, EPS production contributes to

· Biofilm Formation: Allowing the bacterium to adhere to and colonize plant roots effectively.

· Soil Aggregation: Helping to bind soil particles, improving soil structure and water retention.

· Drought Stress Mitigation: Inoculation with EPS-producing B. subtilis strains helps plants tolerate water deficit by improving soil moisture and root association.

Volatile Organic Compounds (VOCs)

B. subtilis emits a complex mixture of volatile compounds that can act as signals, promoting plant growth and inducing systemic resistance against pathogens even without direct contact.

Secondary Metabolites (Identified via GC-MS)

Analysis of B. subtilis culture extracts reveals a wealth of bioactive small molecules.

· Phenol, 3,5-bis(1,1-dimethylethyl): This compound has demonstrated strong antifungal activity by binding to and potentially inhibiting key virulence proteins of fungal pathogens like Fusarium oxysporum.

· Fatty Acids: Palmitic acid, oleic acid, and octadecanoic acid, produced by B. subtilis, contribute to its overall antimicrobial properties.

---

4. Clinical and Therapeutic Applications

Inflammatory Bowel Disease (Crohn's Disease)

This is a significant and promising frontier for Bacillus subtilis in human health. A 2025 Phase I clinical trial is actively investigating the role of B. subtilis supplementation in patients with Crohn's disease receiving infliximab therapy.

· Trial Design: Patients with active Crohn's disease (CDAI ≥150) are being randomized to receive either oral B. subtilis capsules (at a dose of 3×10⁹ CFU once daily) for 12 weeks alongside their standard infliximab treatment, or to a control group receiving only infliximab.

· Rationale: The goal is to determine if supplementing with B. subtilis can enhance the efficacy of the biologic drug infliximab, potentially by modulating the gut microbiome, reducing inflammation, and strengthening the gut barrier.

· Significance: This trial represents a shift towards using next-generation probiotics as adjunctive therapies to improve outcomes in complex immune-mediated diseases.

Irritable Bowel Syndrome with Diarrhea (IBS-D)

A completed randomized, double-blind, placebo-controlled clinical trial has evaluated the efficacy and safety of a probiotic combination containing Bacillus subtilis HU58 and Bacillus coagulans SC208 in patients with IBS-D.

· Study Outcomes: The 28-day trial assessed multiple endpoints, including

· Percentage of responders for abdominal pain and stool consistency

· Changes in stool consistency and abdominal pain intensity

· Changes in Perceived Stress Scale (PSS)

· Percentage of IBS Global Assessment of Improvement Scale (IBS-GAI) responders

· Changes in fecal Short-Chain Fatty Acids (SCFAs) levels, linking probiotic intake to metabolite production

· Changes in gut microbiota diversity via 16S rRNA gene sequencing

· Implications: The completed trial provides evidence for the role of Bacillus species in managing IBS symptoms, with mechanisms potentially involving SCFA production and modulation of the gut microbiome.

Antibiotic-Associated Diarrhea

Bacillus subtilis spores are commonly used to prevent diarrhea associated with antibiotic use. The spores survive the antibiotic's effects and, upon germination, help restore a balanced gut microbiota and competitively exclude opportunistic pathogens like Clostridioides difficile.

Immune Health

B. subtilis has been shown to enhance both innate and adaptive immune responses. It stimulates the activity of macrophages and increases the production of antibodies (IgA, IgG) by activating T and B lymphocytes, contributing to improved resistance against infections.

Cardiometabolic Health

Emerging research suggests that probiotic-induced enrichment of Bacillus species, including B. subtilis, is associated with improvements in metabolic parameters. This may be mediated by the production of SCFAs and other metabolites that influence glucose and lipid metabolism.

Digestive Health

By producing a suite of digestive enzymes (proteases, amylases, lipases, cellulases), B. subtilis directly aids in the breakdown of complex food components, improving nutrient absorption and reducing symptoms of indigestion, gas, and bloating.

Agricultural and Aquaculture Applications (Biocontrol and Growth Promotion)

Beyond human health, Bacillus subtilis is a cornerstone of sustainable agriculture and aquaculture.

· Biocontrol Agent: It effectively suppresses a wide range of plant pathogens, including fungi like Fusarium oxysporum, Rhizoctonia solani, and Botrytis cinerea, as well as bacteria like Erwinia amylovora. Its antifungal metabolites, such as iturin and fengycin, and its ability to outcompete pathogens for nutrients and space, are key mechanisms. In silico studies have shown its metabolites can target and destabilize essential virulence proteins in fungal pathogens.

· Plant Growth Promotion: As a PGPR, B. subtilis colonizes plant roots and promotes growth through multiple mechanisms

· Solubilizing phosphorus and potassium, making these nutrients more available to the plant.

· Producing siderophores that chelate iron, providing it to the plant and depriving pathogens.

· Producing phytohormones like auxins (from tryptophan biosynthesis) that stimulate root growth.

· Inducing Systemic Resistance (ISR), priming the plant's immune system for faster and stronger defense responses.

· Mitigating abiotic stress: Genomic analysis of strains from drought-prone environments reveals genes for osmotolerance, EPS production, and antioxidant responses, which help plants cope with water deficit. Inoculation of maize with such strains under water restriction led to improvements in plant growth parameters of 48 to 306 percent.

Livestock and Poultry Applications

· Feed Efficiency: Supplementation with B. subtilis in animal feed has been shown to improve feed conversion ratios by 5 to 12 percent, reducing feed costs and improving growth performance.

· Gut Health: It reduces the load of pathogenic bacteria like Clostridium perfringens and E. coli in the gut, lowering disease pressure and mortality.

· Processing Tolerance: Its spore form withstands the high temperatures of feed pelleting, with survival rates exceeding 90 percent, ensuring delivery of effective doses.

---

5. Therapeutic Preparations and Formulations

Live Spore Probiotic (Human and Animal)

· Purpose: For general gut health, immune support, antibiotic-associated diarrhea, and as a dietary supplement.

· Formulation and Use: Bacillus subtilis is primarily formulated as stable, dormant spores. These spores are encapsulated in acid-resistant capsules for human use or incorporated into powdered feed additives for livestock. They require no refrigeration and remain viable for 2 to 3 years. Typical human dosages range from 1 to 10 billion CFU per day. The ongoing Crohn's disease trial uses a dose of 3×10⁹ CFU per capsule.

Pasteurized / Paraprobiotic Formulations

· Purpose: For applications where viable cells are not required, such as in some food products or where the goal is to deliver heat-stable components like enzymes or cell wall fragments for immune stimulation.

· Preparation and Use: The bacterial biomass is cultivated and then killed via pasteurization or other methods while retaining some bioactive components.

Spore-Enriched Food Products

· Purpose: To deliver probiotics through functional foods.

· Preparation and Use: Spores are incorporated into foods that do not require refrigeration and where their stability is an advantage. Examples include breakfast cereals, granola bars, chocolates, gummies, and straws.

Agricultural Bioinoculants (Liquid or Powder)

· Purpose: For seed treatment, soil drenching, or foliar application to promote plant growth and control diseases.

· Formulation and Use: B. subtilis is formulated as wettable powders, liquid concentrates, or granular products containing high concentrations of spores. These are applied to crop seeds before planting, to the soil during planting, or directly to plants. They have a long shelf life and are compatible with many agricultural practices.

Synbiotic Formulations

· Purpose: To enhance the efficacy of B. subtilis by providing specific substrates that support its germination and activity.

· Preparation and Use: B. subtilis spores are combined with prebiotic fibers such as fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), or other complex carbohydrates that the vegetative cells can utilize upon germination. This combination aims to improve colonization and metabolic output.

Combination Probiotic Products

· Purpose: To leverage synergistic effects with other probiotic strains.

· Preparation and Use: B. subtilis is frequently combined with other Bacillus species like Bacillus coagulans, Bacillus clausii, or with lactic acid bacteria in multi-strain formulations. The IBS-D trial used a combination of B. subtilis HU58 and B. coagulans SC208.

---

6. In-Depth Mechanistic Profile and Clinical Significance

The Spore: An Engine of Survival and Delivery

The endospore of Bacillus subtilis is arguably its most clinically significant feature. It is not merely a dormant form but a sophisticated delivery vehicle.

· Industrial and Clinical Stability: The spore's resilience allows for manufacturing processes, such as high-temperature feed pelleting, that would decimate other probiotics. It ensures that the product reaches the consumer or animal with guaranteed potency after months or years of storage without a cold chain. This reduces costs and logistical complexity.

· Gastrointestinal Transit: The spore is exquisitely designed to survive the harsh, acidic environment of the stomach and the antimicrobial action of bile in the small intestine. It only germinates when it encounters favorable conditions, ensuring that the active, enzyme-producing vegetative cells are delivered precisely to the target site, the lower small intestine and colon.

· Transient Colonization with Lasting Effect: While B. subtilis does not permanently colonize the gut, its transient presence is sufficient to exert significant biological effects. During its brief period of activity, it produces a burst of enzymes, antimicrobials, and signaling molecules that alter the gut environment, suppress pathogens, and stimulate host immunity, creating a beneficial shift that can outlast the bacterium's physical presence.

Antimicrobial Arsenal: A Multi-Pronged Attack on Pathogens

B. subtilis does not rely on a single mechanism to compete with pathogens. It produces a complex and synergistic cocktail of antimicrobials that target different classes of microorganisms in different ways.

· Broad-Spectrum Activity: The combined action of its lipopeptides (surfactin, iturin, fengycin), bacteriocins (subtilosin, sublancin), and polyketides (bacillaene, difficidin) provides activity against Gram-positive bacteria, Gram-negative bacteria, fungi, and even some viruses. This broad spectrum is rare and highly valuable.

· Anti-Virulence Effects: Recent research using in silico modeling has revealed a sophisticated layer of antifungal action. Metabolites from B. subtilis, such as phenol, 3,5-bis(1,1-dimethylethyl), can bind to and potentially inhibit essential virulence proteins of pathogens like Fusarium oxysporum. By targeting the proteins that pathogens use to infect the host, B. subtilis can disarm them without necessarily killing them, reducing the selective pressure for resistance development.

· Synergy with Host Defenses: The disruption of pathogen cell membranes by surfactin and iturin can make them more susceptible to host immune factors, creating a combined effect that is more powerful than either alone.

Enzyme Production: Unlocking Nutritional Potential

The robust secretory system of B. subtilis allows it to produce and release large quantities of hydrolytic enzymes directly into the gut lumen.

· Direct Nutritional Benefit: For monogastric animals (including humans, poultry, and swine), enzymes like cellulase and phytase break down components of plant-based diets that their own digestive systems cannot handle. This directly increases the energy and nutrients extracted from feed, improving feed efficiency and reducing waste.

· Gut Health Support: By breaking down complex macromolecules, these enzymes may reduce the amount of undigested material reaching the lower gut, which could otherwise be fermented by pathogenic bacteria, leading to gas and inflammation.

Oxygen Consumption and Niche Creation

B. subtilis is primarily an aerobe, meaning it uses oxygen for respiration. By actively consuming oxygen in the gut, it creates a more anaerobic environment.

· Fostering Beneficial Anaerobes: This reduction in oxygen levels favors the growth of strict anaerobes, such as the beneficial Lactobacillus and Bifidobacterium species, which are keystone members of a healthy gut microbiota. In this way, B. subtilis acts as an ecosystem engineer, promoting a more favorable microbial balance.

· Inhibiting Aerobic Pathogens: Many facultative or obligate aerobic pathogens, such as some strains of E. coli and Salmonella, may be disadvantaged by the reduction in oxygen availability.

Immune Modulation: A Balanced Stimulation

B. subtilis interacts with the host immune system in a way that enhances readiness without causing excessive inflammation.

· Innate Immune Activation: Cell wall components and other molecular patterns from B. subtilis are recognized by pattern recognition receptors (like Toll-like receptors) on immune cells. This stimulates the activity of macrophages and natural killer cells, boosting the first line of defense.

· Adaptive Immune Enhancement: It has been shown to increase the proliferation of T and B lymphocytes and enhance antibody production (secretory IgA), strengthening the adaptive immune response and improving immune memory.

· Trained Immunity: Some research suggests that exposure to probiotics like B. subtilis can induce a state of "trained immunity" in innate immune cells, where they exhibit an enhanced response to subsequent infections.

An Integrated View of Healing with Bacillus subtilis

· For Inflammatory Bowel Disease: B. subtilis is being evaluated as an adjunct to biologic therapy. By producing antimicrobials that can suppress dysbiotic pathobionts, secreting enzymes and SCFAs that support gut barrier integrity, and modulating the immune system to a more tolerant state, it could help create a gut environment where the biologic drug infliximab can work more effectively. This multi-targeted approach addresses the complex nature of IBD.

· For Irritable Bowel Syndrome: In IBS-D, the benefits likely stem from its ability to restore a balanced gut microbiota (as evidenced by increased diversity), directly produce SCFAs that regulate gut motility and water absorption, and reduce visceral hypersensitivity through its immunomodulatory effects. The reduction in stress perception in the IBS-D trial also hints at a potential gut-brain axis involvement.

· For Digestive and Metabolic Health: For general consumers, B. subtilis offers a convenient and stable way to support digestion. The direct enzyme supplementation aids in breaking down food, while the production of SCFAs like butyrate (via cross-feeding) provides energy for colon cells and contributes to systemic metabolic regulation.

· In Agriculture and Aquaculture: B. subtilis is a powerful tool for sustainable intensification. It reduces reliance on chemical pesticides and antibiotics by providing natural, multi-faceted protection against diseases. It boosts crop yields and animal productivity by enhancing nutrient availability and mitigating environmental stresses. This positions it as a key component in the global transition towards more environmentally friendly food production systems.

---

7. Dietary Strategies to Support Endogenous B. subtilis

Unlike strict anaerobes that permanently colonize the gut, Bacillus subtilis is a transient member acquired primarily from the environment. Therefore, dietary strategies focus more on creating a favorable environment for its activity after ingestion and for supporting its germination and function.

Consume Fermented Foods

· Sources: Natto, the traditional Japanese fermented soybean dish, is the most well-known dietary source of live Bacillus subtilis var. natto.

· Other Fermented Foods: While not as common, some other fermented vegetables and legumes may contain Bacillus species if they are present in the raw ingredients and survive the fermentation process.

Consume Foods Rich in Plant Fiber

A diet rich in diverse plant fibers supports the overall health of the gut microbiome, creating an ecosystem where transient beneficial bacteria like B. subtilis can have a positive impact.

· Sources: Fruits, vegetables, legumes, and whole grains provide a variety of prebiotic fibers that can be fermented by the gut microbiota, including by the vegetative cells of B. subtilis once they germinate.

Consume Polyphenol-Rich Foods

Polyphenols can have a prebiotic-like effect, supporting beneficial bacteria while inhibiting some pathogens. This creates a favorable environment for B. subtilis activity.

· Sources: Berries, green tea, dark chocolate, coffee, and colorful fruits and vegetables.

---

8. Foods and Factors to Limit

Unnecessary Antibiotic Use

· Broad-spectrum antibiotics, even if they do not directly target spores, can disrupt the gut ecosystem and reduce the potential benefits of any probiotic introduced. Use antibiotics only when prescribed and necessary.

Highly Processed, Low-Fiber Diets

· Diets low in fiber fail to provide the necessary substrates for a healthy gut microbiome. This can limit the positive effects of probiotic supplementation, as the vegetative cells will have fewer nutrients to support their temporary activity.

Excessive Sanitation

· In modern societies, reduced exposure to environmental microbes, including spore-formers from soil and plants, may be a factor in their lower abundance in the gut. While not a dietary factor, this highlights the importance of consuming fermented foods or supplements that provide these beneficial bacteria.

---

9. Therapeutic Potential in Specific Disease States: A Summary

Crohn's Disease (Inflammatory Bowel Disease)

A 2025 Phase I trial is actively investigating its role as an adjunct to infliximab therapy. The goal is to improve clinical efficacy by modulating the gut microbiome, reducing inflammation, and enhancing mucosal healing.

Irritable Bowel Syndrome with Diarrhea (IBS-D)

A completed clinical trial demonstrated the efficacy of a B. subtilis HU58 combination in improving abdominal pain, stool consistency, and quality of life. It also showed increases in fecal SCFAs and gut microbiota diversity.

Antibiotic-Associated Diarrhea

Well-established use. Its spores survive antibiotic treatment, and upon germination, it helps restore a healthy gut microbiota and competitively exclude pathogens like C. difficile.

Infectious Diarrhea

Through competitive exclusion and direct production of antimicrobials, B. subtilis can help suppress common bacterial causes of infectious diarrhea, such as Salmonella and E. coli.

Fungal Infections (Agricultural)

Proven efficacy as a biocontrol agent against a wide range of plant-pathogenic fungi, including Fusarium, Rhizoctonia, and Botrytis species. Its antifungal lipopeptides (iturin, fengycin) are key mediators.

Plant Growth and Drought Stress

Inoculation with B. subtilis strains isolated from harsh environments has been shown to dramatically improve plant growth and survival under water-deficit conditions, by up to 306 percent in maize trials. Its genes for EPS production and osmotolerance are crucial for this effect.

Livestock Production Efficiency

Widely used as a feed additive to improve feed conversion ratios, reduce pathogen load, and enhance growth performance in poultry, swine, and cattle.

---

10. Conclusion

Bacillus subtilis stands as a paragon of probiotic versatility and resilience. Its defining feature, the durable endospore, elevates it above traditional probiotics by offering unparalleled stability in manufacturing, storage, and gastrointestinal transit. This spore is not merely a survival structure but a sophisticated delivery vehicle for a vast arsenal of bioactive compounds.

The scientific landscape of 2025 and 2026 has only deepened our appreciation for this ancient bacterium. From fundamental discoveries in cell biology, revealing how it actively engineers its own rod shape through non-linear mechanical properties of its cell wall, to advanced clinical trials investigating its role in enhancing biologic therapy for Crohn's disease, B. subtilis continues to yield new secrets. Its ability to produce a complex cocktail of antimicrobials that can target and disarm pathogens at a molecular level, as shown in recent in silico studies, positions it as a powerful tool against the growing threat of antimicrobial resistance.

Beyond human health, its role as a cornerstone of sustainable agriculture and aquaculture is more critical than ever. By promoting plant growth, mitigating drought stress, and suppressing diseases naturally, it offers a tangible pathway to reduce our reliance on chemical pesticides and fertilizers. Its widespread use in improving feed efficiency and animal gut health in livestock operations contributes to more sustainable and productive food systems.

With a safety record spanning decades and regulatory approvals across the globe, Bacillus subtilis is not just a promising therapeutic candidate; it is a proven, commercially viable, and deeply understood probiotic that is poised to remain at the forefront of microbiome-directed strategies for human, animal, and environmental health for years to come.

---

11. Reference Books for In-Depth Study

· Bacillus subtilis and Its Closest Relatives: From Genes to Cells by Abraham L. Sonenshein, James A. Hoch, and Richard Losick

· The Human Microbiota and Chronic Disease: Dysbiosis as a Cause of Human Pathology by Luigi Nibali and Brian Henderson

· Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion by Ronald Ross Watson and Victor R. Preedy

· Plant Growth-Promoting Microbes for Sustainable Biotic and Abiotic Stress Management by Heba I. Mohamed, Hossam El-Din Saad El-Beltagi, and Kamel A. Abd-Elsalam

· Beneficial Microbes in Fermented and Functional Foods by V Ravishankar Rai and Jamuna A Bai

· Current research literature in journals including Cell, Nature, Science, Nature Microbiology, Cell Host & Microbe, Gastroenterology, Gut, Applied and Environmental Microbiology, and Plant Disease.

---

12. Further Study: Microbes and Interventions That Might Interest You Due to Similar Therapeutic Properties

Bacillus coagulans

Phylum: Bacillota (Family Bacillaceae)

Similarities: Like B. subtilis, B. coagulans is a spore-forming, lactic acid-producing probiotic with excellent stability. It is frequently used in combination with B. subtilis for gut health, IBS, and immune support. It shares the advantages of spore formation and is also used in both human and animal applications.

Bacillus clausii

Phylum: Bacillota (Family Bacillaceae)

Similarities: Another commercially important spore-forming probiotic, B. clausii is well-known for its use in antibiotic-associated diarrhea and respiratory infections. It is often used in multi-strain Bacillus formulations and shares the same benefits of stability and survival through the gastrointestinal tract.

Lacticaseibacillus casei (specifically strain Zhang)

Phylum: Bacillota (Family Lactobacillaceae)

Similarities: While not spore-forming, L. casei Zhang has been shown in recent 2025 research to significantly enrich A. equolifaciens in the gut. It serves as an example of a probiotic that can modulate the microbiome to support other beneficial bacteria, a function that B. subtilis may also perform through oxygen consumption and SCFA production.

Nattokinase

Intervention: Enzyme derived from Bacillus subtilis var. natto

Similarities: This potent fibrinolytic enzyme is produced during the fermentation of soybeans by B. subtilis in natto. It is used as a supplement for cardiovascular health due to its ability to break down blood clots. It represents a specific bioactive component derived from B. subtilis.

Surfactin and Iturin

Intervention: Purified bioactive metabolites

Similarities: These lipopeptides are key mediators of B. subtilis's antimicrobial activity. Purified surfactin is studied for its potent biosurfactant and anti-mycoplasma properties, while iturin is a powerful antifungal agent. They represent the chemical weapons that give B. subtilis its competitive edge.

---

Disclaimer

Bacillus subtilis is a well-established probiotic with Generally Recognized as Safe (GRAS) status. However, its specific applications as a medical treatment for conditions like Crohn's disease are still under investigation in clinical trials. The effects can be strain-specific and context-dependent. This information is for educational purposes only and is not a substitute for professional medical advice. Always consult with a qualified healthcare provider before starting any new probiotic regimen, especially for individuals who are immunocompromised or have severe underlying health conditions.